Member Info for PCS1954

Think you will find it was Yasmin Evan’s aka Yazz and the Plastic Population who topped with The Way Is Up - Yazoo was a duo of Alison Moyet and Vince Clarke.

Either way, here’s to “UP” in Sareum’s world !!

GLA

Snoop18

Just read your link in detail, a recommended comprehensive summary of the current market -thanks for sharing.

GLA

Joey with due respect I think you will find my link of

https://www.fiercebiotech.com/biotech/jj-protagonists-oral-psoriasis-prospect-bests-bms-sotyktu-pair-phase-3-trials

was fact, so putting anyone’s agenda to one side is more than bleeding obvious!!

GLA

@ Laz - I’m hoping more Spandeau Ballet’s Gold without the fallout over royalties 🤞

@ HBD - speedy and good recovery 👍

@ SOG - agree with your sentiments, as a very small biotech we’re entering the field of play, the larger pharmacy will be aware and have their own pipeline positions to cover going forward - worth revisiting JR’s thoughts of SDC-1801 against Sotyktu.

Anyway, time will tell - dyor!

GLA

HBD , trust you’re well - 👍 thanks for highlighting - me and my full stops !!

GLA

Good morning Laz

One for the oldies perhaps “Silence is Golden”, who knows hopefully find out and to the good soon!!

Meanwhile,

https://www.fiercebiotech.com/biotech/jj-protagonists-oral-psoriasis-prospect-bests-bms-sotyktu-pair-phase-3-trials.

GLA

@LSBM your post shares my belief that there could be other things in play to what seems the obvious, add in Damien’s post regarding 1801 in relation to funding 1802 - there’s many potential “dealings” in the mix that may be a current consideration!

I still also have the opinion that SRA737 is a play - whilst CPF maybe awaiting it’s return (which could have already happened as “within 90 days”) there is nothing to stop Sareum and CPF discussing the future given they are at exactly worst case scenario where they were 14 months ago - I don’t need to list those future options as any opportunity is surely a consideration!

Personally, I’m surprised we haven’t heard anything yet if the BoD are sticking to current RNS intentions, so hence my belief that other things are in play that may be prolonging any statements.

Just my opinion, and may be barking up the wrong tree but I did have a chat with Miss Piggy and she did mention her mates were out and about - dyor!!

GLA

FG

No I don’t have a time limit on news, but I’m expecting news which will come in one form or another when the BoD are ready to announce such.

Yes frustrating at what appears to be very slow progress, but again I believe there are many options in play and despite the criticism of some on this bb, my trust is in the BoD rather than those critiques- if Sareum fail on the science, there’s nothing to play for - as a very small biotech in the large pharma world if they get a half decent foothold I think most rational shareholders will be pleased both scientifically and commercially.

Who knows there may papers to be signed somewhere on a desk, I wait patiently- dyor

GLA

🎣 taken and I go night fishing!!

GLA

Correction fella, you said academic papers were meaningless to commercialise a deal, yet now they’re part of it - also very strange that you take 12 hours to respond after your pals got thread deleted as you made such a hash of it - keep trying with your very obvious agenda very late at night and note your automatic “recommend”💤

GLA

Thanks for sharing and couldn’t agree more Damion, potentially so many plays here just need the BoD consider and finalise the best option, get it in place and announce it - hopefully, we are not too far off of that! 🤞

GLA

Hi SOG

Keep your posts going mate, helluva lot of science content in there that I’m certainly grateful for - leave the sparring out with the “agenda seekers”, gives them nothing to reply to.

I’d rather see debate similar to that of Damion and yourself the other week on SDC 1801 and 1802 compounds - that one thread outstrips a month’s worth of some here!

We all know risk v reward, and have made our decisions accordingly, of course, some just have an agenda!!

Have a good weekend, chill and celebrate WHU’s back to back wins 🍺

GLA

Good morning Krone

Thanks for sharing, a very interesting read showing the competition and speed of the biotech world we are in - interesting caveats on forward looking statements which shows how to market in a positive fashion without breaking rules!!

Here’s hoping Sareum are on the cusp of a similar vibe!

A frosty start here in Cornwall, but, off for beach walk soon at Watergate Bay.

GLA

I’d go along with that view luvleyjubley given TM’s previous links with GSK - as you state “one of the companies reviewing our data” sounds very JR esque!

GLA

For clarification, I didn't say SRA737 had a value - I said, I felt it had a play.

There are many options for SRA737 from the worst case scenario ethically and commercially that of shelving by CPF to the other end of the spectrum, proven safe development and commercialisation with many options in between, by way of example see BH's post below.

Sareum will be shoved into whatever box suits CPF as proved with the last fiasco - and unnamed Biotech.

Apart from complete shelving, whatever box CPF choose, it is an opportunity for Sareum - good or bad, it's what they they do with it - BH's example, I would say is a good option, but, obviously reduces the potential value some have put on here, but, risk v reward may be commercially astute.

All to play for!

GLA

Couldn’t agree more dp, but that said, without a seed you get no flower - I’m looking forward to my summer, how about you?

GLA

Thanks for sharing Krone, still believe SRA737 has a play here for us shareholders!

GLA

* 63k buy

@joey hopefully a £63k buy meets with your measurement of approval and yes the board is ridiculous, but, then again we’re all part of it!!

GLA

Yes indeed!! Interesting that 60k of buys v just over 1k of sells brings no movement in sp - perhaps some of the “manipulation” doubters could explain that one please - I’m all ears!

GLA